Feasibility and Acceptability of a Multi-Modality Self-Management Intervention for Head and Neck Cancer Caregivers: A Pilot Randomized Trial
Overview
Pharmacology
Authors
Affiliations
Background: Head and neck cancer (HNC) patients undergoing radiation therapy (RT) experience significant side effects, presenting challenging care tasks for their informal (unpaid) caregivers. HNC caregivers report low caregiving self-efficacy, high distress, and interest in supportive care interventions.
Objective: This randomized pilot trial assessed the feasibility and acceptability of a 6 to 7 week supported self-management intervention (Prepare to Care) offering psychoeducation and stress management skills building for caregivers of patients receiving RT for HNC.
Methods: Caregivers were randomized to Prepare to Care or standard of care. Primary feasibility measures included participation and retention percentages. Assessments were completed before the intervention, at intervention completion, and 6-weeks later after intervention completion.
Results: Caregivers (N = 38) were predominantly female (88.6%), an average age of 56 years old, and a spouse/partner to the patient (71.4%). Participation percent was 42.2%; retention at intervention conclusion was 80% and 77% at the 6-week follow-up. Quantitative and qualitative results support acceptability, with 64% to 88% reporting each intervention module was helpful (quite a bit or very). Intervention caregivers reported a significantly greater improvement in self-efficacy for progressive muscle relaxation (PMR).
Conclusions: Prepare to Care and the randomized pilot trial methods are feasible and acceptable for HNC caregivers of patients receiving RT. A significant treatment effect was observed for self-efficacy for PMR, and findings were in the expected direction regarding improved caregiving self-efficacy. Further research is necessary to determine the efficacy of this intervention with a focus on increased engagement strategies and longer-term outcomes.
Trial Registration: NCT03032250.
Hughes R, Snavely A, Dressler E, Tegeler C, Nightingale C, Furdui C Future Oncol. 2024; 20(31):2331-2341.
PMID: 39230469 PMC: 11520544. DOI: 10.1080/14796694.2024.2386927.
Johansson B, Cajander A, Ahmad A, Ohlsson-Nevo E, Fransson P, Granstrom B BMC Cancer. 2024; 24(1):494.
PMID: 38637744 PMC: 11025201. DOI: 10.1186/s12885-024-12273-y.
Suresh M, Risbud R, Patel M, Lorenz K, Schapira L, Gallagher-Thompson D Cancer Care Res Online. 2024; 3(4).
PMID: 38328267 PMC: 10846853. DOI: 10.1097/cr9.0000000000000047.
Liu H, Lou V, Xu S BMC Geriatr. 2024; 24(1):86.
PMID: 38263091 PMC: 10804633. DOI: 10.1186/s12877-023-04614-6.
Nightingale C, Snavely A, McLouth L, Dressler E, Kent E, Adonizio C J Natl Cancer Inst. 2023; 116(2):324-333.
PMID: 37738445 PMC: 10852602. DOI: 10.1093/jnci/djad198.